CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Fish oil supplementdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02042274
NCT02042274N/ACompleted
CompareCT.gov

Omega-3 Fatty Acids and Genes Interact to Influence Cardiometabolic Health.

University of Guelph·interventional·Posted Jan 22, 2014·Updated Apr 5, 2017

In Brief

A clinical study evaluating Fish oil supplement for Metabolic Syndrome X. Completed, enrolled 12 participants across 1 site.

Detailed Summary

Fish oil supplements (which are rich in omega-3 fatty acids) have been shown to provide cardiometabolic benefits to individuals of all ages. Specifically, the daily consumption of fish oil supplements has been reported to reduce blood triglyceride levels, and influence glucose homeostasis and whole-body inflammation. However, recent evidence highlights important gaps in our understanding with respect to the impact of fish oil supplements on health; specifically, not everyone responds to these supplements in the same manner. The goal of this research is to explore how an individual's genetic make-up may modify their response to fish oil supplements.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMetabolic Syndrome X
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 22, 2014
Enrollment StartOct 1, 2012
Primary CompletionMar 1, 2013
Study CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 12.4 years ago

Interventions

Fish oil supplementdietary

Participants are instructed to consume fish oil supplements on a daily basis for a 3-month period.